Jens Benn Sørensen

Jens Benn Sørensen

Clinical Associate Professor

Member of:

  • Clinical Oncology


Publication year:
All
21 - 30 out of 106Page size: 10
  1. 2018
  2. Published

    Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment

    Jakobsen, J. N., Santoni Rugiu, Eric, Grauslund, M., Melchior, L. & Sørensen, Jens Benn, 2018, In: OncoTarget. 9, 40, p. 26195-26208

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

    Gandhi, L., Rodríguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., De Angelis, F., Domine, M., Clingan, P., Hochmair, M. J., Powell, S. F., Cheng, S. Y-S., Bischoff, H. G., Peled, N., Grossi, F., Jennens, R. R., Reck, M., Hui, R., Garon, E. B., Boyer, M., Rubio-Viqueira, B. & 19 others, Novello, S., Kurata, T., Gray, J. E., Vida, J., Wei, Z., Yang, J., Raftopoulos, H., Pietanza, M. C., Garassino, M. C., KEYNOTE-189 Investigators, K. I., Boyer, M., Bray, V., Houghton, B. B., Sørensen, Jens Benn, Hansen, K. H., Stelmach, M. J., Walsh, W. V., Wrangle, J. & Wrzesinski, S. H., 2018, In: The New England Journal of Medicine. 378, 22, p. 2078-2092

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. 2017
  5. Published

    Concomitant Driver Mutations in Advanced Stage Non-Small-Cell Lung Cancer of Adenocarcinoma Subtype with Activating EGFR-Mutation

    Sørensen, Jens Benn, Grauslund, M., Melchior, L., Jakobsen, J. N. & Santoni Rugiu, Eric, 2017, In: Journal of Thoracic Oncology. 12, S1, p. S518-S519

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  6. Published

    Heterogeneous Resistance Mechanisms in Rebiopsies from EGFR-Mutated NSCLC: Transformation to SCLC; FGFR3 and T790M Mutations

    Urbanska, E., Grauslund, M., Melchior, L., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2017, In: Journal of Thoracic Oncology. 12, 11 - S2, p. S2203

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  7. Published

    Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation

    Santoni Rugiu, Eric, Grauslund, M., Melchior, L. C., Costa, J. C., Sørensen, Jens Benn & Urbanska, E. M., 2017, In: Lung Cancer. 113, p. 14-17 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Implementation of lung cancer CT screening in the Nordic countries

    Pedersen, J. H., Sørensen, Jens Benn, Saghir, Z., Fløtten, Ø., Brustugun, O. T., Ashraf, H., Strand, T., Friesland, S., Koyi, H., Ek, L., Nyrén, S., Bergman, P., Jekunen, A., Nieminen, E. & Gudbjartsson, T., 2017, In: Acta Oncologica. 56, 10, p. 1249-1257

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial

    Grosso, F., Steele, N., Novello, S., Nowak, A. K., Popat, S., Greillier, L., John, T., Leighl, N. B., Reck, M., Taylor, P., Planchard, D., Sørensen, Jens Benn, Socinski, M. A., von Wangenheim, U., Loembé, A. B., Barrueco, J., Morsli, N. & Scagliotti, G., 2017, In: Journal of Clinical Oncology. 35, 31, p. 3591-3600

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking

    Skov, B. G., Clementsen, P., Larsen, Klaus Richter, Sørensen, Jens Benn & Mellemgaard, A., 2017, In: Histopathology. 70, 6, p. 889-895

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. 2016
  12. Published

    Prospective blinded evaluation predicting efficacy of adjuvant cisplatinum and vinorelbine by a multigene assay after radical surgery in non-small cell lung cancer

    Buhl, I. K., Santoni Rugiu, Eric, Ravn, J., Hansen, A., Christensen, I. J., Jensen, T., Jensen, P. B., Askaa, J., Knudsen, S. & Sørensen, Jens Benn, 2016, In: Journal of Clinical Oncology. e20007.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  13. 2015
  14. Published

    High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural Mesothelioma

    Zimling, Z. G., Santoni Rugiu, Eric, Bech, C. & Sørensen, Jens Benn, Dec 2015, In: Anticancer Research. 35, 12, p. 6731-8 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 34406177